(1/3) Study of real-world effectiveness of the Pfizer-BNT vaccine in Israel in over 1.1 million people.
Any infection: 92% (88-95%)
Symptomatic: 94% (87-98%)
Hospitalisation: 87% (55-100%)
Severe disease 92%% (75-100%)The second dose was crucial.https://t.co/Rvd93hw8Mq pic.twitter.com/r6K6svoGed
— Dr Zoë Hyde (@DrZoeHyde) April 15, 2021
What say ye, doomers?